Optiscan Imaging (ASX:OIL) Common Stock : A$88.53 Mil (As of Jun. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Optiscan Imaging Common Stock?

Optiscan Imaging's quarterly common stock increased from Jun. 2023 (A$71.86 Mil) to Dec. 2023 (A$88.53 Mil) but then stayed the same from Dec. 2023 (A$88.53 Mil) to Jun. 2024 (A$88.53 Mil).

Optiscan Imaging's annual common stock increased from Jun. 2022 (A$71.26 Mil) to Jun. 2023 (A$71.86 Mil) and increased from Jun. 2023 (A$71.86 Mil) to Jun. 2024 (A$88.53 Mil).

Optiscan Imaging Common Stock Historical Data

The historical data trend for Optiscan Imaging's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optiscan Imaging Common Stock Chart

Optiscan Imaging Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Common Stock

Get a 7-Day Free Trial

59.73

70.94

71.26

71.86

88.53

Optiscan Imaging Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Common Stock	Get a 7-Day Free Trial															71.26	71.91	71.86	88.53	88.53

Optiscan Imaging Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Optiscan Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Optiscan Imaging Ltd (ASX:OIL) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170

Website

https://www.optiscan.com

Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.